| 1 |
35123263 | The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione. | 2022 Jan 29 |
1 |
| 2 |
35578055 | Repurposing the natural compounds as potential therapeutic agents for COVID-19 based on the molecular docking study of the main protease and the receptor-binding domain of spike protein. | 2022 May 16 |
1 |
| 3 |
34538222 | Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses. | 2021 Dec |
1 |
| 4 |
34558135 | Vitamin D and COVID-19: A review on the role of vitamin D in preventing and reducing the severity of COVID-19 infection. | 2021 Nov |
1 |
| 5 |
32656452 | Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor. | 2020 Jul 7 |
1 |
| 6 |
33250972 | SARS-CoV2 infectivity is potentially modulated by host redox status. | 2020 |
2 |
| 7 |
26195630 | Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9. | 2015 Sep 18 |
1 |